Your browser doesn't support javascript.
loading
Characteristics, healthcare utilization, and outcomes of patients with HER2-low breast cancer.
Check, Devon K; Jackson, Bradford E; Reeder-Hayes, Katherine E; Dinan, Michaela A; Faherty, Eleanor; Kwong, Jackie; Mehta, Sandhya; Spees, Lisa; Wheeler, Stephanie B; Wilson, Lauren E; Lam, Clara.
Affiliation
  • Check DK; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Suite 210, Durham, NC, 27701, USA. Devon.check@duke.edu.
  • Jackson BE; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Reeder-Hayes KE; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Dinan MA; Yale Cancer Center, New Haven, CT, USA.
  • Faherty E; AstraZeneca, Gaithersburg, MD, USA.
  • Kwong J; Daiichi Sankyo, Basking Ridge, NH, USA.
  • Mehta S; Daiichi Sankyo, Basking Ridge, NH, USA.
  • Spees L; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Wheeler SB; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Wilson LE; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Suite 210, Durham, NC, 27701, USA.
  • Lam C; AstraZeneca, Gaithersburg, MD, USA.
Breast Cancer Res Treat ; 203(2): 329-338, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37875669
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2024 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2024 Document type: Article Affiliation country: United States